1989 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
2018

Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials

D'Agostino, M., De Paoli, L., Conticello, C., Offidani, M., Ria, R., Petrucci, M. T., Spada, S., Marcatti, M., Catalano, L., Gilestro, M., Guglielmelli, T., Baldini, L., Gamberi, B., Rizzi, R., De Sabbata, G., Di Renzo, N., Patriarca, F., Pezzatti, S., Siniscalchi, A., Ribolla, R. & 5 others, Palumbo, A., Montefusco, V., Nagler, A., Boccadoro, M. & Gay, F., Dec 2018, In : Critical Reviews in Oncology/Hematology. 132, p. 9-16 8 p.

Research output: Contribution to journalReview article

Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials

D'Agostino, M., De Paoli, L., Conticello, C., Offidani, M., Ria, R., Petrucci, M. T., Spada, S., Marcatti, M., Catalano, L., Gilestro, M., Guglielmelli, T., Baldini, L., Gamberi, B., Rizzi, R., De Sabbata, G., Di Renzo, N., Patriarca, F., Pezzatti, S., Siniscalchi, A., Ribolla, R. & 5 others, Palumbo, A., Montefusco, V., Nagler, A., Boccadoro, M. & Gay, F., Dec 1 2018, In : Critical Reviews in Oncology/Hematology. 132, p. 9-16 8 p.

Research output: Contribution to journalReview article

Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis

Bringhen, S., Offidani, M., Palmieri, S., Pisani, F., Rizzi, R., Spada, S., Evangelista, A., Di Renzo, N., Musto, P., Marcatti, M., Vallone, R., Storti, S., Bernardini, A., Centurioni, R., Aitini, E., Palmas, A., Annibali, O., Angelucci, E., Ferrando, P., Baraldi, A. & 9 others, Rocco, S., Andriani, A., Siniscalchi, A., De Stefano, V., Meneghini, V., Palumbo, A., Grammatico, S., Boccadoro, M. & Larocca, A., Oct 2018, In : Critical Reviews in Oncology/Hematology. 130, p. 27-35 9 p.

Research output: Contribution to journalReview article

Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis

Bringhen, S., Offidani, M., Palmieri, S., Pisani, F., Rizzi, R., Spada, S., Evangelista, A., Di Renzo, N., Musto, P., Marcatti, M., Vallone, R., Storti, S., Bernardini, A., Centurioni, R., Aitini, E., Palmas, A., Annibali, O., Angelucci, E., Ferrando, P., Baraldi, A. & 9 others, Rocco, S., Andriani, A., Siniscalchi, A., De Stefano, V., Meneghini, V., Palumbo, A., Grammatico, S., Boccadoro, M. & Larocca, A., Oct 1 2018, In : Critical Reviews in Oncology/Hematology. 130, p. 27-35 9 p.

Research output: Contribution to journalReview article